| 标题 |
Atopic Dermatitis 相关领域
特应性皮炎
免疫学
丝状蛋白
医学
免疫系统
钙调神经磷酸酶
免疫失调
胸腺基质淋巴细胞生成素
敏化
炎症
疾病
免疫球蛋白E
抗体
病理
内科学
移植
|
| 网址 | |
| DOI |
提醒:求助人提供的doi与AI识别不一致
10.1038/s41572-018-0001-z
Doi
|
| 其它 |
Author: Aaron Drucker, MD, ScM , Abstract Atopic dermatitis affects approximately 10% of the U.S. population and is more common in children than adults. Up to 99% of physician visits for atopic dermatitis are in primary care. Most cases can be managed successfully with topical treatments, including moisturizers and prescription anti-inflammatory treatments, such as corticosteroids, calcineurin inhibitors, phosphodiesterase-4 inhibitors, Janus kinase (JAK) inhibitors, and aryl hydrocarbon receptor agonists. For more refractory or severe atopic dermatitis, ultraviolet phototherapy and systemic treatments, usually prescribed by specialists, can be used. Systemic treatments include older off-label immunomodulators, such as methotrexate. Since 2017, multiple on-label injectable biologics and oral JAK inhibitors have been approved. |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
|
温馨提示:该文献已被科研通 学术中心 收录,前往查看
科研通『学术中心』是文献索引库,收集文献的基本信息(如标题、摘要、期刊、作者、被引量等),不提供下载功能。如需下载文献全文,请通过文献求助获取。
|
PDF的下载单位、IP信息已删除
(2025-6-4)